Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer - Contacts and Locations

Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00003418

Locations


Belgium
	U.Z. Gasthuisberg
	Leuven, Belgium, B-3000

France
	Centre Antoine Lacassagne
	Nice, France, 06189

United Kingdom, England
	Charing Cross Hospital
	London, England, United Kingdom, W6 8RF

Sponsors and Collaborators

International Collaborative Cancer Group

European Organization for Research and Treatment of Cancer

Federation Nationale des Centres de Lutte Contre le Cancer

Investigators


Study Chair:	R. Charles Coombes, MD, MRCP, FRCP, PhD, FMedSci	Charing Cross Hospital

Study Chair:	Robert Paridaens, MD, PhD	U.Z. Gasthuisberg

Study Chair:	Moise Namer, MD, PhD	Centre Antoine Lacassagne